Frequency of community-acquired pneumonia in children aged 5 to 12 years in the Provincial Health Center N°48 of the city of Rosario, Argentina in 2023
DOI:
https://doi.org/10.56294/hl2024.277Keywords:
community-acquired pneumonia, pediatric patients, risk factors, symptoms, treatmentAbstract
Introduction: Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in children under 10 years of age. In recent years, an increase in the incidence of complicated pneumonia in children has been observed.
Methods: To describe the frequency of community-acquired pneumonia in children aged 5 to 12 years at the Provincial Health Center N°48 in the city of Rosario, Argentina, in 2023. Materials and methods: Quantitative, descriptive, cross-sectional, retrospective study. It was carried out at the Provincial Health Center N°48. The population consisted of all pediatric patients of both sexes, aged between 5 and 12 years, who had been treated as outpatients or inpatients for a diagnosis of community pneumonia. The data collection instrument was the patients' medical records. The statistical analysis consisted of a descriptive analysis of quantitative variables through absolute and relative percentage frequencies.
Results: We found 30 medical records of pediatric patients diagnosed with community-acquired pneumonia. Of these, 53% were female and 47% male; with a mean age of 8.37 ± 2.51 years (min.3; max. 12). It was found that 40% of the cases presented asthma, bronchial hyperreactivity and recurrent respiratory infections, 33% presented malnutrition, 20% had premature birth, 10% had chronic diseases, 7% attended day care centers and 3% lived in overcrowded conditions. Among the main symptoms associated with the diagnosis of the disease, there was a gradual onset, fever higher than 38.5°, productive cough, chills, myalgia and arthralgias. The treatment used in 90% of the cases was Amoxicillin orally at a dose of 80-100mg/kg every 8 hours for 7 days.
Conclusions: A low frequency of CAP (4%) was found in pediatric patients under 12 years of age. Asthma, bronchial hyperreactivity and recurrent respiratory infections were risk factors present in the studied population. Clinical manifestations of CAP were fever higher than 38.5°, productive cough, chills, myalgias and arthralgias. Amoxicillin was used orally at a dose of 80-100mg/kg every 8 hours for 7 days as the first treatment option
References
1. Agudelo VB. Neumonía adquirida en la comunidad en pediatría: Latinoamérica. Neumol Pediatr. 2021;8(2):51-52. https://doi.org/10.51451/np.v8i2.402
2. Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: W B Saunders; 2014.
3. Bernztein R, Drake I. Neumonía de la comunidad en niños: impacto sanitario y costos del tratamiento en el primer nivel de atención público de la Argentina. Arch Argent Pediatr. 2009;107(2):101-110. http://www.scielo.org.ar/scielo.php?pid=S0325-00752009000200002&script=sci_arttext
4. Black AD. Non-infectious mimics of community-acquired pneumonia. Pneumonia (Nathan Qld). 2016;8:2. https://doi.org/10.1186/s41479-016-0002-1
5. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7)
. https://doi.org/10.1093/cid/cir531
6. Chang CC, Cheng AC, Chang AB. Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults. In: Chang CC, editor. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 2007.
7. Chang TH, Liu YC, Lin SR, Chiu PH, Chou CC, Chang LY, et al. Clinical characteristics of hospitalized children with community-acquired pneumonia and respiratory infections: using machine learning approaches to support pathogen prediction at admission. J Microbiol Immunol Infect. 2023;56(4):772-781.
8. Davis C, Padilla R. Factores de riesgo socioculturales asociados a neumonía adquirida en la comunidad desde la cosmovisión indígena Miskitu en niños menores de 5 años [tesis doctoral]. Universidad de las Regiones Autónomas de la Costa Caribe Nicaragüense (URACCAN); 2020.
9. Díaz JP, Val AS, Trallero GR. Dolor torácico. Pediatría Integral. 2024;7:49. https://www.pediatriaintegral.es/wp-content/uploads/2024/xxviii01/06/n1-049-057_MariaMartin.pdf
10. Ensinck G. Neumonía adquirida de la comunidad: ¿qué hay de nuevo? [diapositivas]. 2014. https://www.sap.org.ar/docs/congresos/2014/Infecto%20presentaciones/Ensinck_SAMR-Co.pdf
11. Ensinck G, Lazarte G, Ernst A, Romagnoli A, López Papucci S, Aletti A, et al. Neumonía por Staphylococcus aureus resistente a meticilina adquirida de la comunidad en un hospital pediátrico. Nuestra experiencia de 10 años. Arch Argent Pediatr. 2021;119:11-17.
12. Giménez F, Sánchez A, Battles JM, López JA, Sánchez-Solís M. Características clínico-epidemiológicas de la neumonía adquirida en la comunidad en niños menores de 6 años. An Pediatr (Barc). 2007;66(6):578-584. https://doi.org/10.1157/13107392
13. Gobierno de Argentina. La neumonía en niños: problemas persistentes para su adecuada caracterización y tratamiento. Buenos Aires: Ministerio de Salud; 2005. Disponible en: https://bancos.salud.gob.ar/sites/default/files/2020-06/boletin-remediar-18.pdf
14. González J, Julián-Jiménez A, Candel FJ, Servicio de Urgencias, IdISSC, Hospital Clínico San Carlos, Madrid, España. Community-acquired pneumonia: selection of empirical treatment and sequential therapy. SARS-CoV-2 implications. Rev Esp Quimioter. 2021;34(6):599-609. https://doi.org/10.37201/req/144.2021
15. Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66(Suppl 2)
. https://doi.org/10.1136/thoraxjnl-2011-200598
16. Jiménez AI, López-Neyra A, Sanz V, Álvarez-Coca J, Villa JR. Estudio de la función pulmonar en niños tras neumonía adquirida en la comunidad en edad preescolar. An Pediatr (Barc). 2011;75(5):314-319. https://doi.org/10.1016/j.anpedi.2011.05.002
17. Jullien S, Pradhan D, Tshering T, Sharma R, Dema K, Garcia-Garcia S, et al. Pneumonia in children admitted to the national referral hospital in Bhutan: A prospective cohort study. Int J Infect Dis. 2020;95:74-83. https://doi.org/10.1016/j.ijid.2020.04.017
18. Kabra SK, Lodha R, Pandey RM. Antibiotics for community-acquired pneumonia in children. Cochrane Database Syst Rev. 2010;(3)
. https://doi.org/10.1002/14651858.CD004874.pub3
19. Kasundriya SK, Dhaneria M, Mathur A, Pathak A. Incidence and risk factors for severe pneumonia in children hospitalized with pneumonia in Ujjain, India. Int J Environ Res Public Health. 2020;17(13):4637. https://doi.org/10.3390/ijerph17134637
20. Kliegman RM, St Geme JW. Nelson Textbook of Pediatrics. 21st ed. Philadelphia: Elsevier; 2019.
21. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology. 2004;9(1):109-114. https://doi.org/10.1111/j.1440-1843.2003.00522.x
22. Lanzotti ME. Antibióticos en la comunidad: abordaje ambulatorio de la neumonía [diapositivas]. 2017. https://www.sap.org.ar/docs/Congresos2017/Infectolog%C3%ADa/Lunes%2024/Dra._Lanzotti_controversias_en_el_abordaje.pdf
23. Madurga LE, Jalle EM, Sánchez NG, de Benavides MC, Álvarez MJL, Casanova MG. Actitud diagnóstico-terapéutica en la neumonía adquirida en la comunidad en niños de 3 meses a 14 años. Boletín Soc Pediatr Aragón, Rioja, Soria. 2011;41(2):41-46.
24. Magaña SPA. Perfil clínico y epidemiológico de pacientes de 3 meses a 12 años con diagnóstico de neumonía adquirida en la comunidad, referidos por necesidad de soporte ventilatorio al Hospital Nacional de Niños Benjamín Bloom, entre 1 de enero de 2012 y 31 de diciembre de 2017 [tesis]. 2020. https://docs.bvsalud.org/biblioref/2020/10/1127649/18-11106266.pdf
25. Martín A, Moreno-Pérez D, Alfayate S, Couceiro JA, García ML, Korta J, et al. Etiología y diagnóstico de la neumonía adquirida en la comunidad y sus formas complicadas. An Pediatr (Barc). 2012;76(3):162.e1-162.e18. https://doi.org/10.1016/j.anpedi.2011.09.011
26. Martínez CJ, Flores SA, Pesantez AD, Suquinagua MD, Bravo CA, Guevara MC. Prevalencia de la neumonía en pacientes pediátricos en Latinoamérica durante el periodo 2017-2022. Mediciencias UTA. 2022;6(4):108-122. https://doi.org/10.31243/mdc.uta.v6i4.1819.2022
27. Ministerio de Salud de la Nación. Boletín Integrado de Vigilancia N° 410– SE 22. 2018. https://bancos.salud.gob.ar/sites/default/files/2020-01/biv_410_se22.pdf
28. Moreno DL, Moreno L, Ferrero F, Vidaurreta S, Nadeo J, Abram L, et al. Recomendaciones para el manejo de las infecciones respiratorias agudas bajas en menores de 2 años. Arch Argent Pediatr. 2021;119(4)
. https://doi.org/10.5546/aap.2021.s171
29. Moreno-Pérez D, Andrés A, Tagarro A, Escribano A, Figuerola J, García JJ, et al. Neumonía adquirida en la comunidad: tratamiento ambulatorio y prevención. An Pediatr (Barc). 2015;83(6):439.e1-439.e7. https://doi.org/10.1016/j.anpedi.2014.10.028
30. Organización Mundial de la Salud. The management of acute respiratory infections in children: practical guidelines for outpatient care. Ginebra: OMS; 1995.
31. Redondo E, Rivero I, Vargas D, Mascarós E, Díaz-Maroto J, Linares M, et al. Vacunación frente a la neumonía adquirida en la comunidad del adulto. Posicionamiento del Grupo de Neumoexpertos en Prevención. SEMERGEN. 2016;42(7):464-475. https://doi.org/10.1016/j.semerg.2016.07.009
32. Renz DM, Huisinga C, Pfeil A, Böttcher J, Schwerk N, Streitparth F, et al. Röntgenuntersuchungen des Thorax bei Kindern und Jugendlichen: Indikationen und Limitationen. Der Radiologe. 2022;62(2):140-148. https://doi.org/10.1007/s00117-021-00954-9
33. Sociedad Peruana de Enfermedades Infecciosas y Tropicales, Organización Panamericana de la Salud. Guía de práctica clínica: neumonía adquirida en la comunidad en niños. Lima: Ministerio de Salud del Perú; 2009. https://bvs.minsa.gob.pe/local/MINSA/2419.pdf
34. Úbeda I, Croche B, Hernández A. Guía-ABE. Infecciones en Pediatría. Guía rápida para la selección del tratamiento antimicrobiano empírico. 2020. http://www.guiaabe.es
35. Virkki R, Juven T, Rikalainen H, Svedström E, Mertsola J, Ruuskanen O. Differentiation of bacterial and viral pneumonia in children. Thorax. 2002;57(5):438-441. https://doi.org/10.1136/thorax.57.5.438
36. Visbal Spirko LP, Galindo López J, Orozco Cepeda K, Vargas Rumilla MI. Neumonía adquirida en la comunidad en pediatría. Rev Cienc Salud Uninorte. 2007;23(2):43-48. https://rcientificas.uninorte.edu.co/index.php/salud/article/view/4038
Published
Issue
Section
License
Copyright (c) 2024 Julieta Ivana Passas , Mónica Gustafsson (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
